Table 4 Univariate analysis of prognostic factors for Os and EFS*

> 10

56

33.8

97.8

94.2

0.01

0.06

< 10

110

66.2

86.6

89.4

Sex

Female

116

69.8

89.4

96

0.84

0.6

Male

50

30.2

92.9

87

Histology

Ns

80

48.1

93

95

0.08

0.21

Mc

57

34.3

86.4

90

Lp

26

15.6

98

80.4

Dl

3

1.8

88.6

87

Stage

I

19

11.7

94.5

93

0.005

0.02

II

60

36.4

91

91

III

55

32.1

82.5

80

IV

32

19.8

71

69

Radiotherapy

Yes

146

87.9

91

94

0.003

0.07

No

20

12.1

72

88

RT dose

= < 21 GY

112

79.6

92.5

88.4

0.76

0.5

>21 Gy

34

20.4

89.1

90.2

Chemotherapy

ABVD

66

40,9

90.4

91

0.16

0.15

MOOP

22

13,6

92.6

88

VEEP

17

10,5

90.7

91.2

OTHERS

56

34,7

88.8

86

Symptoms B

Present

114

68.7

77.4

69.5

0.0001

0.0001

Absent

52

31.3

97.3

96.4

Mediast involved

Present

16

9.7

90

89

0.7

0.5

Absent

150

90.3

92.9

91